Literature DB >> 32490454

C(sp3)-H arylation to construct all-syn cyclobutane-based heterobicyclic systems: a novel fragment collection.

Thomas J Osberger1, Sarah L Kidd2, Thomas A King2, David R Spring2.   

Abstract

All-syn fused cyclobutanes remain an elusive chemotype and thus present an interesting synthetic challenge. Herein, we report the successful application of Pd-catalysed C(sp3)-H arylation of cyclobutane compounds to generate all-syn heterobicyclic fragments using an innovative 'inside-out' approach. Through this strategy we generate a virtual collection of 90 fragments, which we demonstrate to have enhanced three-dimensionality and superior fragment-like properties compared to existing collections.

Entities:  

Year:  2020        PMID: 32490454     DOI: 10.1039/d0cc03237a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

Review 1.  Fragment-to-Lead Medicinal Chemistry Publications in 2020.

Authors:  Iwan J P de Esch; Daniel A Erlanson; Wolfgang Jahnke; Christopher N Johnson; Louise Walsh
Journal:  J Med Chem       Date:  2021-12-20       Impact factor: 7.446

2.  Oxa-spirocycles: synthesis, properties and applications.

Authors:  Kateryna Fominova; Taras Diachuk; Dmitry Granat; Taras Savchuk; Vladyslav Vilchynskyi; Oleksiy Svitlychnyi; Vladyslav Meliantsev; Igor Kovalchuk; Eduard Litskan; Vadym V Levterov; Valentyn R Badlo; Ruslan I Vaskevych; Alla I Vaskevych; Andrii V Bolbut; Volodymyr V Semeno; Rustam Iminov; Kostiantyn Shvydenko; Anastasiia S Kuznetsova; Yurii V Dmytriv; Daniil Vysochyn; Vasyl Ripenko; Andrei A Tolmachev; Olexandra Pavlova; Halyna Kuznietsova; Iryna Pishel; Petro Borysko; Pavel K Mykhailiuk
Journal:  Chem Sci       Date:  2021-07-27       Impact factor: 9.825

3.  Puckering the Planar Landscape of Fragments: Design and Synthesis of a 3D Cyclobutane Fragment Library.

Authors:  David J Hamilton; Marieke Beemsterboer; Caroline M Carter; Jasmina Elsayed; Rilana E M Huiberts; Hanna F Klein; Peter O'Brien; Iwan J P de Esch; Maikel Wijtmans
Journal:  ChemMedChem       Date:  2022-03-30       Impact factor: 3.540

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.